Tyra Biosciences, Inc. (TYRA)
35.07
+0.53
(+1.53%)
USD |
NASDAQ |
Mar 06, 16:00
35.07
0.00 (0.00%)
After-Hours: 20:00
Tyra Biosciences Research and Development Expense (TTM) : 102.38M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Spyre Therapeutics, Inc. | 171.65M |
| Agios Pharmaceuticals, Inc. | 334.36M |
| BridgeBio Pharma, Inc. | 451.95M |
| Nuvalent, Inc. | 306.97M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |